Predictors of Responsiveness to GLP-1 Receptor Agonists in Insulin-Treated Patients with Type 2 Diabetes

Table 3

Number of patients to discontinue prandial insulin based on random C-peptide (low <0.8 ng/ml vs. normal ≥0.8 ng/ml).

		Low C-peptide	Normal C-peptide	(2-sided Fisher’s exact test)
3 months	Discontinued prandial insulin	0	11
	Total	7	23	0.029
6 months	Discontinued prandial insulin	0	8
	Total	4	20	0.262
12 months	Discontinued prandial insulin	1	7
	Total	8	23	0.642